Christopher Haqq - Net Worth and Insider Trading

Christopher Haqq Net Worth

The estimated net worth of Christopher Haqq is at least $154,701 dollars as of 2024-05-11. Christopher Haqq is the EVP, R&D & Chief Scientific Of of Atara Biotherapeutics Inc and owns about 291,943 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $154,701. Details can be seen in Christopher Haqq's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Haqq has not made any transactions after 2019-02-15 and currently still holds the listed stock(s).

Transaction Summary of Christopher Haqq

To

Christopher Haqq Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Haqq owns 4 companies in total, including Atara Biotherapeutics Inc (ATRA) , Surrozen Inc (SRZN) , and Consonance-HFW Acquisition Corp (CHFW.U) among others .

Click here to see the complete history of Christopher Haqq’s form 4 insider trades.

Insider Ownership Summary of Christopher Haqq

Ticker Comapny Transaction Date Type of Owner
ATRA Atara Biotherapeutics Inc 2019-02-15 Chief Medical Officer
SRZN Surrozen Inc 2021-08-11 other: Former Director
CHFW.U Consonance-HFW Acquisition Corp 2021-08-11 other: Former Director
2023-06-01 See Remarks

Christopher Haqq Latest Holdings Summary

Christopher Haqq currently owns a total of 1 stock. Christopher Haqq owns 291,943 shares of Atara Biotherapeutics Inc (ATRA) as of February 15, 2019, with a value of $154,701.

Latest Holdings of Christopher Haqq

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATRA Atara Biotherapeutics Inc 2019-02-15 291,943 0.53 154,701

Holding Weightings of Christopher Haqq


Christopher Haqq Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Haqq has made a total of 0 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years. The most-recent trade in Atara Biotherapeutics Inc is the sale of 775 shares on February 15, 2019, which brought Christopher Haqq around $30,682.

Insider Trading History of Christopher Haqq

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Haqq Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Haqq Ownership Network

Ownership Network List of Christopher Haqq

No Data

Ownership Network Relation of Christopher Haqq


Christopher Haqq Owned Company Details

What does Atara Biotherapeutics Inc do?

Who are the key executives at Atara Biotherapeutics Inc?

Christopher Haqq is the Chief Medical Officer of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , EVP & Chief Sci. & Tech Officer Anhco Nguyen , and SVP & CFO Eric J Hyllengren .

Atara Biotherapeutics Inc (ATRA) Insider Trades Summary

Over the past 18 months, Christopher Haqq made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 151,346 shares made by Pascal Touchon , a net sale of 43,245 shares made by Amar Murugan , and a net sale of 34,741 shares made by Eric J Hyllengren .

In summary, during the past 3 months, insiders sold 56,192 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 56,192 shares. During the past 18 months, 337,881 shares of Atara Biotherapeutics Inc (ATRA) were sold and 816,825 shares were bought by its insiders, resulting in a net purchase of 478,944 shares.

Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Atara Biotherapeutics Inc Insider Transactions

No Available Data

Christopher Haqq Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Haqq. You might contact Christopher Haqq via mailing address: C/o Atara Biotherapeutics, Inc., 3260 Bayshore Boulevard, Brisbane Ca 94005.

Discussions on Christopher Haqq

No discussions yet.